INTERCEPT PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q4 2011 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Intercept Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2011 to Q3 2023.
  • Intercept Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2023 was 41.8M shares, a 0.95% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 41.8M +395K +0.95% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 41.8M +12M +40.2% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 41.7M +12M +40.3% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 41.5M +12M +40.4% Dec 31, 2022 10-Q 2023-11-06
Q3 2022 41.4M +11.9M +40.2% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 29.8M -3.4M -10.3% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 29.7M -3.45M -10.4% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 29.6M -3.44M -10.4% Dec 31, 2021 10-K 2023-03-02
Q3 2021 29.5M -3.45M -10.4% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 33.2M +220K +0.67% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 33.2M +217K +0.66% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 33M +163K +0.5% Dec 31, 2020 10-K 2022-03-02
Q3 2020 33M +259K +0.79% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 33M +284K +0.87% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 32.9M +3.16M +10.6% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 32.9M +3.16M +10.6% Dec 31, 2019 10-K 2021-02-25
Q3 2019 32.7M +3.08M +10.4% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 32.7M +3.13M +10.6% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 29.8M +4.45M +17.5% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 29.7M +4.52M +18% Dec 31, 2018 10-K 2020-02-25
Q3 2018 29.7M +4.55M +18.1% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 29.6M +4.46M +17.8% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 25.3M +320K +1.28% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 25.2M +353K +1.42% Dec 31, 2017 10-K 2019-03-01
Q3 2017 25.1M +311K +1.26% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 25.1M +424K +1.72% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 25M +418K +1.7% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 24.8M +428K +1.76% Dec 31, 2016 10-K 2018-02-28
Q3 2016 24.8M +536K +2.21% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 24.7M +527K +2.18% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 24.6M +1.89M +8.31% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 24.4M +2.98M +13.9% Dec 31, 2015 10-K 2017-03-01
Q3 2015 24.3M +2.93M +13.7% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 24.1M +2.97M +14% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 22.7M +3.14M +16% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 21.4M +2.03M +10.4% Dec 31, 2014 10-K 2016-02-29
Q3 2014 21.3M +2.02M +10.5% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 21.2M +2.14M +11.2% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 19.6M +2.93M +17.6% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 19.4M +2.86M +17.3% Dec 31, 2013 10-K 2015-03-02
Q3 2013 19.3M +16M +480% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 19M Jun 30, 2013 10-Q 2013-08-13
Q1 2013 16.6M Mar 31, 2013 10-Q 2013-05-14
Q4 2012 16.5M +13.2M +396% Dec 31, 2012 10-Q 2013-11-14
Q3 2012 3.33M Sep 30, 2012 10-Q/A 2012-12-21
Q4 2011 3.33M Dec 31, 2011 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.